drugset
Drugs / 18F-Fluoro Dopa
last change Sep 2020 re-read 3 minutes ago

18F-Fluoro Dopa

also known as 18F-DOPA · 6-[18F]-Fluoro-L-3,4,-dihydroxyphenylalanine
Investigated by
St. Louis Children's Hospital · Washington University School of Medicine

Trials 1

today NCT05088798 · Ph 2
2021202220232024202520262027202820292030
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05088798 Sep 2020 → Jan 2030 expected hyperinsulinism Washington University School of Medicine Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 18F-Fluoro Dopa ClinicalTrials.gov intervention name — accepted as the source's own label NCT05088798 ↗
Known as 18F-DOPA “6-\[18F\]-Fluoro-L-3,4,-dihydroxyphenylalanine (18F-DOPA)positron emission tomography (PET)” NCT05088798 ↗
Known as 6-[18F]-Fluoro-L-3,4,-dihydroxyphenylalanine “6-\[18F\]-Fluoro-L-3,4,-dihydroxyphenylalanine (18F-DOPA)positron emission tomography (PET)” NCT05088798 ↗